James Bono, MD
Adult Reconstructive Orthopaedic Surgery · Boston, MANPI 1164598801
Payments from drug & device makers
Across 453 payments — averaging $13,825 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$6.3M
- Wishbone Medical Inc.$150
- Globus Medical$126
- Medline Industries LP$40
What the payments were for
- Royalty or licence$6,145,76398%
- Consulting fees$41,6751%
- Travel & lodging$62,3271%
- Food & beverage$13,0140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 450 | $6,262,463 |
| Wishbone Medical Inc. | 1 | $150 |
| Globus Medical | 1 | $126 |
| Medline Industries LP | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCOLADE$6,166,233
- TRIDENT$2,729,872
- TRIATHLON$2,065,681
- MAKO$65,913
- TRITANIUM$5,000
- NEW PRODUCT DEVELOPMENT$2,916
- SURPASS EVOLVE$999
- INSIGNIA$463
- RESTORIS$382
- Pulse$126
How this compares
$6,262,779 in reported general payments places this provider in the 95th percentile of 24 adult reconstructive orthopaedic surgery providers in Massachusetts.
See all adult reconstructive orthopaedic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 39 | $1,795 |
| Oxycodone Hcl | 123 | $518 |
| Mupirocin | 38 | $200 |
| Amoxicillin | 132 | $173 |
| Ondansetron Hcl | 44 | $101 |
| Hydromorphone Hcl | 17 | $65 |
| Tramadol Hcl | 40 | $49 |
| Clindamycin Hcl | 23 | $26 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Boston
- Vivek ShahBoston$1.4M
- Eric SmithBoston$721K
- John HarrisBoston$57K
- Hayden BoxBoston$38K
- Peter WhiteBoston$9K
- Anoop PrasadBoston$9K
- Marcantonio PinciBoston$7K
- Senthil SambandamBoston$4K
- Thomas KaneBoston$4K
- Jorge Villafuerte VallejosBoston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.